PERIOPERATIVE USE OF BLOOD COMPONENTS DURING HEART, LUNG AND PANCREAS-KIDNEY TRANSPLANTATION FROM BRAIN-DEAD DONORS

T. Kiyokawa, M. Oshida, K. Nagamine, S. Hayashi, Y. Kurata
{"title":"PERIOPERATIVE USE OF BLOOD COMPONENTS DURING HEART, LUNG AND PANCREAS-KIDNEY TRANSPLANTATION FROM BRAIN-DEAD DONORS","authors":"T. Kiyokawa, M. Oshida, K. Nagamine, S. Hayashi, Y. Kurata","doi":"10.3925/JJTC1958.50.699","DOIUrl":null,"url":null,"abstract":"Perioperative blood use for 15 organ transplantations from brain-dead donors performed at Osaka University Hospital during 1999 and 2002 was reviewed. Seven heart transplantations were performed with a median blood component use of 105 units, which consisted of 32 (range, 14-41) units of red cell component (MAP), 34 (range, 10-56) units of fresh-frozen plasma (FFP), and 39 (range, 0-95) units of platelet concentrates (PC). Five lung transplantations were done with a median blood component use of 51 units, which consisted of 18 (range, 4-41) units of MAP, 17 (range, 0-44) units of FFP, and 16 (range, 0-35) units of PC, and 3 pancreas-kidney transplantations were done with a median use of 8 units, which consisted of 5 (range, 4-8) units of MAP and 3 units of FFP. As far as possible, CMV-negative blood components were supplied irrespective of CMV status of donor or recipient. These data should be useful in the planning of perioperative blood order schedules for organ transplantation from brain-dead donors.","PeriodicalId":86521,"journal":{"name":"Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion","volume":"50 1","pages":"699-703"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3925/JJTC1958.50.699","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Perioperative blood use for 15 organ transplantations from brain-dead donors performed at Osaka University Hospital during 1999 and 2002 was reviewed. Seven heart transplantations were performed with a median blood component use of 105 units, which consisted of 32 (range, 14-41) units of red cell component (MAP), 34 (range, 10-56) units of fresh-frozen plasma (FFP), and 39 (range, 0-95) units of platelet concentrates (PC). Five lung transplantations were done with a median blood component use of 51 units, which consisted of 18 (range, 4-41) units of MAP, 17 (range, 0-44) units of FFP, and 16 (range, 0-35) units of PC, and 3 pancreas-kidney transplantations were done with a median use of 8 units, which consisted of 5 (range, 4-8) units of MAP and 3 units of FFP. As far as possible, CMV-negative blood components were supplied irrespective of CMV status of donor or recipient. These data should be useful in the planning of perioperative blood order schedules for organ transplantation from brain-dead donors.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脑死亡供体心脏、肺和胰脏肾移植围手术期血液成分的使用
回顾了1999年和2002年在大阪大学医院进行的15例脑死亡供体器官移植的围手术期用血情况。7例心脏移植中位血液成分使用量为105单位,其中包括32单位(范围14-41)红细胞成分(MAP), 34单位(范围10-56)新鲜冷冻血浆(FFP)和39单位(范围0-95)血小板浓缩物(PC)。5例肺移植中位血成分用量为51单位,其中MAP为18单位(范围4-41),FFP为17单位(范围0-44),PC为16单位(范围0-35);3例胰肾移植中位血成分用量为8单位,MAP为5单位(范围4-8),FFP为3单位。尽可能提供CMV阴性的血液成分,而不考虑供者或受者的CMV状况。这些数据对于脑死亡供者器官移植围手术期血单安排的规划是有用的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
THE EFFECT OF GLYCEROL-3-PHOSPHATE ON STORAGE OF CPD PRESERVED WHOLE BLOOD THE DISTRIBUTION OF HLA-A, B, C, Bf, C4 AND TWO LOCUS ASSOCIATION OF HEALTHY APHERESIS DONNOR IN YAMAGUCHI PREFECTURE, WESTERN AREA OF JAPAN RE-EXAMINATION OF BERNSTEIN'S CORRECTIONS TO THE MULTI-ALLELOMORPHISM IN THE ABO BLOOD GROUPS CLINICAL SIGNIFICANCE OF SERIAL EXAMINATION OF ANTI HUMAN IMMUNODEFICIENCY VIRUS ( HIV ) ANTIBODY AND HIV ANTIGEN IN HEMOPHILIACS WITH HIV INFECTION A NEW ADDITIVE SOLUTION CONTAINING PHOSPHOENOLPYRUVATE (PEP) FOR PLASMA AND LEUKOCYTE POOR RED CELL CONCENTRATES I. PEP for Red Cells Preservation as a Protein-Free-Medium
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1